Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $2.45M; Research and development $24.36M; Operating expenses $31.78M; Net income -$26.10M.
2026-03-31: Revenue $2.77M; Research and development $20.41M; Operating expenses $28.15M; Net income -$22.25M.
2025-12-31: Revenue $3.08M*; Research and development $24.50M*; Operating expenses $31.50M*; Net income -$25.94M*.
2025-09-30: Revenue $2.05M; Research and development $18.51M; Operating expenses $25.19M; Net income -$20.17M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.